Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Veru
Veru
(VERU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sacituzumab
urologic neoplasms
,
carcinoma
,
transitional cell carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
Enobosarm
breast density
,
urinary incontinence
,
stress urinary incontinence
,
enuresis
,
triple negative breast neoplasms
,
obesity
,
breast neoplasms
,
wasting syndrome
,
cachexia
,
muscular atrophy
,
non-small-cell lung carcinoma
,
lung neoplasms
Aglatimagene besadenovec
renal cell carcinoma
,
colonic neoplasms
,
bone diseases
,
urethral neoplasms
,
transitional cell carcinoma
,
neuroendocrine carcinoma
,
neoplasms
,
carcinoma
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
urologic neoplasms
,
small cell lung carcinoma
,
breast neoplasms
,
lung neoplasms
,
melanoma
,
neuroendocrine tumors
,
ovarian neoplasms
,
uterine cervical neoplasms
,
small cell carcinoma
,
adenocarcinoma
,
triple negative breast neoplasms
,
colorectal neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
squamous cell carcinoma
,
aggression
,
disease progression
,
squamous cell carcinoma of head and neck
,
recurrence
,
pancreatic neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
ovarian epithelial carcinoma
,
neoplasm metastasis
,
hypersensitivity
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
prostatic hyperplasia
,
hyperplasia
,
disease susceptibility
Sabizabulin
breast neoplasms
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
syndrome
,
triple negative breast neoplasms
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
severe acute respiratory syndrome
,
covid-19
,
infections
Bevifimod
fibrosis
,
cystic fibrosis
,
pulmonary fibrosis
Enclomiphene
neoplasms
Insulin
healthy volunteers/patients
,
glycemic control
,
aggression
,
hypersensitivity
,
neoplasms
,
insulin resistance
,
carcinoma
,
colonic neoplasms
,
rectal neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
hyperinsulinism
,
neuroendocrine tumors
,
hypoglycemia
,
chronic renal insufficiency
,
kidney diseases
,
glucose metabolism disorders
,
metabolic diseases
,
endocrine system diseases
,
obesity
,
cardiovascular diseases
,
chronic obstructive pulmonary disease
,
asthma
,
sepsis
,
septic shock
,
shock
,
toxemia
,
overweight
,
weight gain
,
diabetes mellitus
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
hyperglycemia
,
schizophrenia
,
metabolic syndrome
,
gestational diabetes
,
myocardial infarction
,
infarction
,
inferior wall myocardial infarction
,
psychotic disorders
,
prediabetic state
,
disease progression
,
pancreatitis
,
patient participation
,
peripheral nervous system diseases
,
diabetic neuropathies
,
glucose intolerance
Viaject
type 1 diabetes mellitus
,
hypoglycemia
,
diabetes mellitus
Pd0332991
healthy volunteers/patients
,
pancreatic neoplasms
,
castration-resistant prostatic neoplasms
,
endometrioid carcinoma
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
melanoma
,
colorectal neoplasms
,
urinary bladder neoplasms
,
unknown primary neoplasms
,
pancreatic ductal carcinoma
,
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
myelodysplastic syndromes
,
preleukemia
,
acute disease
,
non-small-cell lung carcinoma
,
lung neoplasms
,
triple negative breast neoplasms
,
multiple myeloma
,
leukemia
,
ovarian neoplasms
,
non-hodgkin lymphoma
,
adenocarcinoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
lymphoma
,
mantle-cell lymphoma
,
sarcoma
,
head and neck neoplasms
,
squamous cell neoplasms
,
plasma cell neoplasms
,
ovarian epithelial carcinoma
,
brain neoplasms
,
renal cell carcinoma
,
colonic neoplasms
,
bone neoplasms
,
neuroblastoma
,
medulloblastoma
,
rhabdoid tumor
,
ewing sarcoma
,
rhabdomyosarcoma
,
diffuse intrinsic pontine glioma
,
small cell lung carcinoma
,
intraductal carcinoma noninfiltrating
,
b-cell lymphoma
,
prostatic neoplasms
,
second primary neoplasms
,
glioma
,
oligodendroglioma
,
transitional cell carcinoma
,
myeloid leukemia acute
,
myeloid leukemia
,
hepatocellular carcinoma
,
liver neoplasms
,
glioblastoma
,
gliosarcoma
,
astrocytoma
,
liposarcoma
,
kidney diseases
,
urologic neoplasms
,
urogenital neoplasms
,
kidney neoplasms
,
urologic diseases
,
neoplasms by site
,
glandular and epithelial neoplasms
,
neoplasms
,
carcinoma
,
squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
male breast neoplasms
,
neoplasm metastasis
,
recurrence
,
disease progression
,
breast neoplasms
,
radiotherapy
Enclomiphene citrate
prostatic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use